Feeds
4301 items (4301 unread) in 74 feeds
Acinar Cell Carcinoma
(73 unread)
Acinic Cell Carcinoma
(53 unread)
Adenoid Cystic Carcinoma
(264 unread)
Adrenal Gland Cancer
(299 unread)
Ampulla Of Vater
(55 unread)
Anal Cancer
(374 unread)
Angiosarcoma
(75 unread)
Appendix Cancer
(95 unread)
Bile Duct Cancer
(420 unread)
Brain and CNS
(464 unread)
Carcinoid
(70 unread)
Endocrine/Neuroendocrine
(637 unread)
Gall Bladder Cancer
(90 unread)
Hemangioendothelioma
(149 unread)
Hepatoblastoma
(67 unread)
Pancreas
(72 unread)
Phyllodes
(61 unread)
PMP and Mucinous Tumors
(79 unread)
Rhabdomyosarcoma
(96 unread)
Sarcoma
(808 unread)
Google - Neuroendocrine Tumor (40 unread)
-
A Rare Presentation of a Duodenal Neuroendocrine Tumor - Cureus
Posted: January 13th, 2023, 2:03pm GMT
-
A Phase 1/2 Study of MRT-2359 in People with Advanced Lung ... - On Cancer - Memorial Sloan Kettering
Posted: January 13th, 2023, 1:34pm GMT
A Phase 1/2 Study of MRT-2359 in People with Advanced Lung ... On Cancer - Memorial Sloan Kettering -
FDA Grants Orphan Drug Designation for JBI-802 in SCLC and AML - Targeted Oncology
Posted: January 13th, 2023, 12:00am GMT
FDA Grants Orphan Drug Designation for JBI-802 in SCLC and AML Targeted Oncology -
New computational tools widen horizons for liquid biopsies - Fred Hutch News Service
Posted: January 12th, 2023, 9:57pm GMT
New computational tools widen horizons for liquid biopsies Fred Hutch News Service -
ADXS-504 Study Increases Enrollment After Confirming Safety in ... - OncLive
Posted: January 12th, 2023, 6:46pm GMT
-
Medullary Thyroid Cancer Management: 5 Things to Know - Medscape
Posted: January 12th, 2023, 5:05pm GMT
-
Bassett Cancer Institute rolls out new treatment option - The Central New York Business Journal
Posted: January 12th, 2023, 1:53pm GMT
Bassett Cancer Institute rolls out new treatment option The Central New York Business Journal -
Novel Cell "Switches" Promote Lung Cancer Growth - Technology Networks
Posted: January 12th, 2023, 7:47am GMT
Novel Cell "Switches" Promote Lung Cancer Growth Technology Networks -
Hemicolectomy versus appendectomy for patients with appendiceal ... - The Lancet
Posted: January 11th, 2023, 9:36pm GMT
-
BXCL701 Plus Pembrolizumab Generates Promising Responses in ... - OncLive
Posted: January 11th, 2023, 7:04pm GMT
-
JPM23, Day 3: Takeda relishing in-person meetups - FierceBiotech
Posted: January 11th, 2023, 12:46pm GMT
JPM23, Day 3: Takeda relishing in-person meetups FierceBiotech -
RICHARD HAGGERTY Obituary (2023) - Philadelphia, PA - The ... - Legacy.com
Posted: January 11th, 2023, 6:00am GMT
-
Regeneron Science Talent Search high school semifinalists 2023 - The Journal News
Posted: January 10th, 2023, 3:15pm GMT
Regeneron Science Talent Search high school semifinalists 2023 The Journal News -
Jasper pulls out of pivotal blood cancer trial at last minute - FierceBiotech
Posted: January 10th, 2023, 1:20pm GMT
-
Review of Hematology-Oncology Emergencies for Internal Medicine ... - Cureus
Posted: January 10th, 2023, 12:02am GMT
-
John Piorkowski Obituary (1963 - 2022) - Legacy.com
Posted: January 6th, 2023, 6:52pm GMT
John Piorkowski Obituary (1963 - 2022) Legacy.com -
2022 drug approvals: Biopharma delivered 34 new drugs - FiercePharma
Posted: January 3rd, 2023, 6:00am GMT
-
Independence Valued Over Survival for Neuroendocrine Tumor ... - Physician's Weekly
Posted: December 30th, 2022, 6:00am GMT
Independence Valued Over Survival for Neuroendocrine Tumor ... Physician's Weekly -
Neuroendocrine Cancer: Types, Causes, and Symptoms - Verywell Health
Posted: December 23rd, 2022, 6:00am GMT
Neuroendocrine Cancer: Types, Causes, and Symptoms Verywell Health -
First test of anti-cancer agent PAC-1 in human clinical trials shows ... - Science Daily
Posted: December 22nd, 2022, 6:00am GMT
-
CAPTEM in advanced neuroendocrine neoplasms | CMAR - Dove Medical Press
Posted: December 21st, 2022, 6:00am GMT
CAPTEM in advanced neuroendocrine neoplasms | CMAR Dove Medical Press -
A woman was experiencing abdominal pain 'worse than labor.' What ... - The Daily Briefing
Posted: December 21st, 2022, 6:00am GMT
A woman was experiencing abdominal pain 'worse than labor.' What ... The Daily Briefing -
A Sea Change in Treatment for von Hippel-Lindau Disease - Curetoday.com
Posted: December 20th, 2022, 6:00am GMT
A Sea Change in Treatment for von Hippel-Lindau Disease Curetoday.com -
Three-drug regimen shows promise in neuroendocrine carcinoma of ... - MIMS
Posted: December 18th, 2022, 6:00am GMT
-
Clinical Trial of Roswell Park's SurVaxM Glioblastoma Vaccine ... - Roswell Park Comprehensive Cancer Center
Posted: December 16th, 2022, 6:00am GMT
Clinical Trial of Roswell Park's SurVaxM Glioblastoma Vaccine ... Roswell Park Comprehensive Cancer Center -
Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel ... - Physician's Weekly
Posted: December 6th, 2022, 6:00am GMT
Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel ... Physician's Weekly -
Cushing's Seen in Woman With Rare Neuroendocrine Cervical ... - Cushing's Disease News
Posted: November 30th, 2022, 6:00am GMT
Cushing's Seen in Woman With Rare Neuroendocrine Cervical ... Cushing's Disease News -
Proteogenomic landscape and clinical characterization of GH ... - Nature.com
Posted: November 27th, 2022, 6:00am GMT
-
Presentation of Lung Carcinoid Tumor as Post-obstructive Pneumonia - Cureus
Posted: November 24th, 2022, 6:00am GMT
-
Exploring neuroendocrine tumors, cancer that can act like other ... - WPVI-TV
Posted: November 21st, 2022, 6:00am GMT
-
Minimally Invasive Technique Ablates Pancreatic Insulinoma - Medscape
Posted: November 18th, 2022, 6:00am GMT
-
Capecitabine–Temozolomide Therapy for Pancreatic ... - NEJM Journal Watch
Posted: November 16th, 2022, 6:00am GMT
Capecitabine–Temozolomide Therapy for Pancreatic ... NEJM Journal Watch -
Recurrent Neuroendocrine Tumor of the Cervix Presenting With ... - Cureus
Posted: November 15th, 2022, 6:00am GMT
-
Addition of Capecitabine to Temozolomide in Advanced Pancreatic ... - The ASCO Post
Posted: November 1st, 2022, 5:00am GMT
-
FDA Grants Fast Track Designation to ITM-11 for ... - OncLive
Posted: October 28th, 2022, 5:00am GMT
-
The real-world selection of first-line systemic therapy regimen for ... - Nature.com
Posted: October 20th, 2022, 5:00am GMT
-
RUNDC3A regulates SNAP25-mediated chemotherapy resistance ... - Nature.com
Posted: June 25th, 2022, 5:00am GMT
-
FDA Issues Complete Response Letter to Surufatinib for Advanced ... - OncLive
Posted: May 2nd, 2022, 5:00am GMT
-
Multifocal Solid and Serous Cystadenomas and a Neuroendocrine ... - American College of Surgeons
Posted: May 1st, 2022, 8:38pm GMT
Multifocal Solid and Serous Cystadenomas and a Neuroendocrine ... American College of Surgeons -
Peptide Receptor Radionuclide Therapy for Refractory Mid-Gut ... - NEJM Journal Watch
Posted: April 1st, 2022, 5:00am GMT
Peptide Receptor Radionuclide Therapy for Refractory Mid-Gut ... NEJM Journal Watch